Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies

被引:40
|
作者
Lin, Richard J. [1 ]
Elko, Theresa A. [1 ]
Devlin, Sean M. [2 ]
Shahrokni, Armin [3 ,4 ]
Jakubowski, Ann A. [1 ,4 ]
Dahi, Parastoo B. [1 ,4 ]
Perales, Miguel-Angel [1 ,4 ]
Tamari, Roni [1 ,4 ]
Shaffer, Brian C. [1 ,4 ]
Sauter, Craig S. [1 ,4 ]
Papadopoulos, Esperanza B. [1 ,4 ]
Gyurkocza, Boglarka [1 ,4 ]
Korc-Grodzicki, Beatriz [3 ,4 ]
Barker, Juliet N. [1 ,4 ]
Maloy, Molly A. [1 ]
Giralt, Sergio A. [1 ,4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Adult BMT Serv, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Geriatr Serv, 1275 York Ave, New York, NY 10021 USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
ACUTE MYELOID-LEUKEMIA; COMORBIDITY INDEX; RISK-ASSESSMENT; SURVIVAL; AGE; VALIDATION; FERRITIN; ALBUMIN;
D O I
10.1038/s41409-019-0654-6
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Older patients are at increased risk for complications and death following allogeneic hematopoietic cell transplantation (allo-HCT). Traditional transplant-specific prognostic indices such as hematopoietic cell transplant comorbidity index (HCT-CI) may not capture all underlying geriatric vulnerabilities, and in-depth evaluation by a geriatrician prior to transplant may not always be available. We hypothesize that routine pretransplant interdisciplinary clinical assessment may uncover prognostically important geriatric deficits. Using an institutional database of 457 adults aged 60 years and older who underwent first allo-HCT for hematological malignancies from 2010 to 2017, we examined the prognostic impact of pretransplant deficits in geriatric domains of function, mobility, mood, medication, nutrition, and relevant biochemical markers. We found that impairment in instrumental activities of daily living (IADL) was associated with reduced survival through increased nonrelapse mortality (NRM, HR=1.82; 95% CI, 1.04-3.19). The combination of IADL impairment with either HCT-CI/age index or disease risk index readily stratified NRM and overall survival, respectively. In addition, we found that even mild renal dysfunction adversely impacted survival in older transplant patients. Our findings establish important geriatric vulnerabilities in older patients prior to allo-HCT and may provide an entry point for prospective, interventional trials to improve their outcomes.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [1] Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies
    Richard J. Lin
    Theresa A. Elko
    Sean M. Devlin
    Armin Shahrokni
    Ann A. Jakubowski
    Parastoo B. Dahi
    Miguel-Angel Perales
    Roni Tamari
    Brian C. Shaffer
    Craig S. Sauter
    Esperanza B. Papadopoulos
    Boglarka Gyurkocza
    Beatriz Korc-Grodzicki
    Juliet N. Barker
    Molly A. Maloy
    Sergio A. Giralt
    Bone Marrow Transplantation, 2020, 55 : 157 - 164
  • [2] Impact of geriatric vulnerability on outcomes of older patients in allogeneic hematopoietic cell transplantation.
    Lin, Richard Jirui
    Elko, Theresa A.
    Devlin, Sean M.
    Flynn, Jessica
    Jakubowski, Ann Alice
    Shahrokni, Armin
    Dahi, Parastoo
    Perales, Miguel-Angel
    Sanchez-Escamilla, Miriam
    Tamari, Roni
    Shaffer, Brian Carl
    Sauter, Craig Steven
    Papadopoulos, Esperanza Bouza
    Castro-Malaspina, Hugo
    Gyurkocza, Boglarka
    Barker, Juliet Naomi
    Maloy, Molly A.
    Korc-Grodzicki, Beatriz
    Giralt, Sergio
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [3] Outcomes in Patients Age 70 or Older Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Brunner, Andrew M.
    Kim, Haesook T.
    Coughlin, Erin
    Alyea, Edwin P., III
    Armand, Philippe
    Ballen, Karen K.
    Cutler, Corey
    Dey, Bimalangshu R.
    Glotzbecker, Brett
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ho, Vincent T.
    Chen, Yi-Bin
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (09) : 1374 - 1380
  • [4] GERIATRIC ASSESSMENT AND OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN OLDER PATIENTS
    Dahi, Parastoo B.
    Shahrokni, Armin
    Flynn, Jessica
    Devlin, Sean M.
    Chinapen, Stephanie A.
    Ayala, Jennifer
    Brown, Soni
    Bugen, Sarah
    Cho, Christina
    Gyurkocza, Boglarka
    Kim, Soo Jung
    Lin, Richard
    Papadopoulos, Esperanza B.
    Perales, Miguel-Angel
    Politikos, Ioannis
    Ponce, Doris M.
    Shaffer, Brian C.
    Shah, Gunjan
    Tamari, Roni
    Young, James W.
    Giralt, Sergio A.
    Jakubowski, Ann A.
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 540 - 540
  • [5] Outcomes of Patients Older Than Age 70 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for Hematologic Malignancies
    Brunner, Andrew M.
    Chen, Yi-Bin
    Kim, Haesook
    Coughlin, Erin
    Alyea, Edwin P., III
    Armand, Philippe
    Ballen, Karen
    Cutler, Corey
    Dey, Bimalangshu R.
    Glotzbecker, Brett
    Koreth, John
    McAfee, Steven L.
    Spitzer, Thomas R.
    Soiffer, Robert J.
    Antin, Joseph H.
    Ho, Vincent T.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S114 - S114
  • [6] Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies
    Montserrat Vera-Llonch
    Gerry Oster
    Colleen M. Ford
    John Lu
    Stephen Sonis
    Supportive Care in Cancer, 2007, 15 : 491 - 496
  • [7] Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies
    Vera-Llonch, Montserrat
    Oster, Gerry
    Ford, Colleen M.
    Lu, John
    Sonis, Stephen
    SUPPORTIVE CARE IN CANCER, 2007, 15 (05) : 491 - 496
  • [8] Outcomes after Second Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
    Huselton, Eric
    Slade, Michael
    Abboud, Camille
    Cashen, Amanda
    DiPersio, John F.
    Ghobadi, Armin
    Pusic, Iskra
    Romee, Rizwan
    Uy, Geoffrey L.
    Vij, Ravi
    Westervelt, Peter
    Schroeder, Mark A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S278 - S278
  • [9] Allogeneic Peripheral Blood Hematopoietic Stem Cell Transplantation for Patients with Hematologic Malignancies
    夏凌辉
    方峻
    游泳
    郭涛
    刘芳
    张纯
    江汇娟
    邹萍
    华中科技大学学报(医学英德文版), 2006, (01) : 47 - 49
  • [10] Allogeneic peripheral blood hematopoietic stem cell transplantation for patients with hematologic malignancies
    Xia Linghui
    Fang Jun
    You Yong
    Guo Tao
    Liu Fang
    Zhang Chun
    Jiang Huijuan
    Zou Ping
    Journal of Huazhong University of Science and Technology [Medical Sciences], 2006, 26 (1): : 47 - 49